Developer docs
API playgroundTry for free, no card

Search company profiles

Ligence

Full company profile

uuid0002363

Namestring
Ligence
Legal namestring
Ligence (UAB)
Websiteurl
ligence.io
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Ligence is a Lithuanian deep tech / health tech company developing Ligence Heart, an FDA 510(k)-cleared and CE-marked web-based software platform that automates echocardiography (cardiac ultrasound) analysis and reporting for cardiologists and sonographers. The product applies deep learning neural networks to perform automated view classification across standard imaging planes (PLAX, A2CH, A3CH, A4CH), cardiac cycle phase detection, and a broad set of measurements including ejection fraction (EF), LV dimensions, transmitral E/A velocities, tissue Doppler, aortic valve hemodynamics, and global longitudinal peak systolic strain (GLPS). Results are delivered via DICOM SR and DICOM GSPS into existing hospital PACS, EHR, and cloud infrastructure, with automated report generation aligned to EACVI, BSE, and ASE clinical guidelines.

The company operates a vertical SaaS business model, selling annual subscriptions to hospital cardiology departments performing high volumes of 2D transthoracic echocardiography and offering an integration channel to PACS vendors seeking echocardiography-specific AI without in-house R&D investment. Pricing is quote-based rather than publicly disclosed, and a website value calculator frames the economic case around time savings (claimed at up to 50% reduction in reporting time, with customer testimonials citing ~15 minutes saved per patient). Regulatory and compliance positioning is a core commercial asset: FDA 510(k) clearance (initial plus a second for automated LV strain), CE Mark, ISO 13485, and GDPR compliance. The company has raised a €2.5 million EIC Accelerator grant (2022) and a €3 million seed round (November 2024, led by Simpact Ventures), with cumulative funding exceeding €5.5M when including earlier Lithuanian innovation grants, and is now scaling commercial operations across Europe while running US clinical trials ahead of broader American market entry.

Short descriptiontext

Ligence builds Ligence Heart, an FDA-cleared and CE-marked AI platform that automates echocardiography analysis and reporting for hospital cardiology departments and PACS vendors across Europe and the US.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVilnius, Lithuania
HQ citystring
Vilnius
HQ countrystring
Lithuania
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
echocardiography analysis software, cardiac ultrasound AI, medical imaging automation, cardiology reporting software, heart image analysis
Industry2 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI
NAICS code1 code
  • Software Publishers5132
Product category
Cardiac Ultrasound AI Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Ligence Heart SaaS Subscription
TypeSubscription Recurring
Description

Ligence Heart is a web-based, out-of-the-box software solution sold as a subscription to hospitals and cardiology practices. The software automates echocardiography analysis and reporting, integrating directly with existing PACS infrastructure. Revenue is generated through per-echo or subscription-based pricing, with value calculators suggesting per-study economics.

ligence.io
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Others
Pricing details1 tier
1Enterprise/SaaS subscription for hospital cardiology departments
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing is quote-based and not publicly listed. The website features a value calculator where hospitals input country, price per echo, number of echoes per day, and images taken by cardiologist or non-doctor to calculate time savings and economic value.

ligence.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Ligence develops Ligence Heart™, an FDA Cleared and CE-Marked web-based software that uses deep learning neural networks to automatically analyze 2D transthoracic echocardiography (2D TTE) images. The product classifies cardiac views, detects heart cycle phases, performs automated measurements (e.g., ejection fraction, LV dimensions, strain), and generates guideline-based echocardiography reports (EACVI, BSE, ASE) for hospital cardiology departments and PACS vendors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 15 minutes saved per patient in echocardiography reporting
+2 more records
Product overview1 text field

Ligence offers a unified cardiac diagnostics platform centered on Ligence Heart™, an FDA Cleared and CE-Marked echocardiography analysis software. The core product automates cardiac ultrasound analysis using deep learning for view classification, image segmentation, and automated measurements. An add-on module, Ligence Heart for PACS, extends these capabilities to external PACS systems through DICOM integration. The platform generates structured diagnostic reports following clinical guidelines (EACVI, BSE, ASE) and targets cardiologists and sonographers to reduce echocardiography reporting time and improve diagnostic accuracy.

Product and service2 records
1Ligence Heart™
CategoryCardiac Ultrasound AI Software
Description

FDA Cleared and CE-Marked web-based echocardiography analysis and reporting software that automates cardiac ultrasound image analysis using deep learning. It classifies heart views (PLAX, A2CH, A3CH, A4CH), detects systolic and diastolic phases, performs automated measurements (EF, LV dimensions, transmitral E/A velocities, tissue Doppler, strain), and generates structured reports following EACVI, BSE, or ASE guidelines for cardiologists and sonographers.

2Ligence Heart for PACS
CategoryCardiac Imaging Integration Module
Description

Integration module for PACS vendors and radiology networks that embeds Ligence's automated echocardiography measurements and analysis into PACS platforms via DICOM SR/GSPS formats, including an HTML5 DICOM viewer. Designed for PACS companies seeking to add AI-powered echocardiography capability without in-house R&D investment.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierPartnerTypeTechnology or Integration
Description

Clarius is listed as a partner on Ligence's website. Clarius produces handheld ultrasound scanners, and the partnership likely involves integration of Ligence's AI-powered echocardiography analysis with Clarius ultrasound devices.

Strategic tierPartnerTypeTechnology or Integration
Description

CARPL is listed as a partner on Ligence's website. CARPL is a radiology AI platform that enables integration of multiple AI models; the partnership likely involves CARPL hosting or distributing Ligence's cardiac AI within its platform ecosystem.

Strategic tierPartnerTypeTechnology or Integration
Description

DeepC is listed as a partner on Ligence's website. DeepC provides a deep learning infrastructure platform, and the partnership may relate to AI model deployment, training infrastructure, or joint go-to-market in the radiology AI space.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Caption Health
TypeDirect peer
Description

AI-powered echocardiography guidance and analysis software, acquired by GE HealthCare in 2024. Direct competitor in automated cardiac ultrasound measurement and reporting for cardiology workflows.

TypeDirect peer
Description

UK-based AI echocardiography company offering EchoWeave and EchoGo for automated cardiac analysis including strain and HFpEF detection. Directly competes with Ligence Heart in automated echo measurement and reporting for hospital cardiology departments.

TypeDirect peer
Description

Singapore-based AI echocardiography platform automating cardiac measurements and reporting for clinical and clinical trial use. Competes head-to-head with Ligence Heart in automated echo analysis.

TypeBroad incumbent
Description

Global ultrasound OEM integrating AI-based cardiac quantification (e.g., HeartModel) into its EPIQ/Affiniti platforms. A broad incumbent that bundles AI echo features natively into PACS-connected systems, putting competitive pressure on standalone AI vendors like Ligence.

TypeBroad incumbent
Description

Global imaging OEM and ultrasound vendor that acquired Caption Health. Competes with Ligence by bundling AI-driven echo automation into its Vscan Air and premium ultrasound consoles plus Centricity PACS.

TypeBroad incumbent
Description

Cardiac imaging AI features integrated into Siemens ACUSON ultrasound and syngo.via platforms, providing automated echo measurements and broader radiology AI that overlaps with Ligence's analysis-and-reporting value proposition.

TypeDirect peer
Description

Echocardiography analysis software (now part of Philips) automating 2D/3D cardiac measurements including strain and 3D volumes. Long-standing specialist peer in clinical echo analysis and reporting that Ligence competes with directly.

TypeEmerging player
Description

AI-driven cardiac MR and CT analysis platform. Overlaps with Ligence's automated measurement approach and represents a cross-modality competitor that could expand into echo.

TypeEmerging player
Description

AI-driven cardiac MRI acquisition and analysis platform. Comparable in clinical AI positioning and FDA-clearance trajectory, with potential future overlap in multi-modality cardiac diagnostics.

TypeRegional player
Description

AI-enabled handheld/portable ultrasound with embedded cardiac measurement automation. Comparable in combining AI with echo to automate cardiac workflows, but sold more as a device-plus-AI bundle rather than pure software like Ligence Heart.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ligence

Cardiac Ultrasound AI Softwareligence.io

Ligence builds Ligence Heart, an FDA-cleared and CE-marked AI platform that automates echocardiography analysis and reporting for hospital cardiology departments and PACS vendors across Europe and the US.

What Ligence does

Ligence is a Lithuanian deep tech / health tech company developing Ligence Heart, an FDA 510(k)-cleared and CE-marked web-based software platform that automates echocardiography (cardiac ultrasound) analysis and reporting for cardiologists and sonographers. The product applies deep learning neural networks to perform automated view classification across standard imaging planes (PLAX, A2CH, A3CH, A4CH), cardiac cycle phase detection, and a broad set of measurements including ejection fraction (EF), LV dimensions, transmitral E/A velocities, tissue Doppler, aortic valve hemodynamics, and global longitudinal peak systolic strain (GLPS). Results are delivered via DICOM SR and DICOM GSPS into existing hospital PACS, EHR, and cloud infrastructure, with automated report generation aligned to EACVI, BSE, and ASE clinical guidelines.

The company operates a vertical SaaS business model, selling annual subscriptions to hospital cardiology departments performing high volumes of 2D transthoracic echocardiography and offering an integration channel to PACS vendors seeking echocardiography-specific AI without in-house R&D investment. Pricing is quote-based rather than publicly disclosed, and a website value calculator frames the economic case around time savings (claimed at up to 50% reduction in reporting time, with customer testimonials citing ~15 minutes saved per patient). Regulatory and compliance positioning is a core commercial asset: FDA 510(k) clearance (initial plus a second for automated LV strain), CE Mark, ISO 13485, and GDPR compliance. The company has raised a €2.5 million EIC Accelerator grant (2022) and a €3 million seed round (November 2024, led by Simpact Ventures), with cumulative funding exceeding €5.5M when including earlier Lithuanian innovation grants, and is now scaling commercial operations across Europe while running US clinical trials ahead of broader American market entry.

Ligence firmographics

Firmographics
Name
Ligence
Legal name
Ligence (UAB)
Website
https://ligence.io
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Ligence builds Ligence Heart, an FDA-cleared and CE-marked AI platform that automates echocardiography analysis and reporting for hospital cardiology departments and PACS vendors across Europe and the US.
Ownership category
akta.pro rank

Ligence industry classification

Industry
Product category
Cardiac Ultrasound AI Software
NAICS
Software Publishers (5132)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAH
Medical Imaging AI

Keywords

  • Echocardiography analysis software
  • Cardiac ultrasound AI
  • Medical imaging automation
  • Cardiology reporting software
  • Heart image analysis

Where Ligence is headquartered

Location

Headquarters

HQ city
Vilnius
HQ country
Lithuania
HQ region
Europe

Offices1 record

Markets served

Ligence business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

  1. Ligence Heart SaaS Subscription: Ligence Heart is a web-based, out-of-the-box software solution sold as a subscription to hospitals and cardiology practices. The software automates echocardiography analysis and reporting, integrating directly with existing PACS infrastructure. Revenue is generated through per-echo or subscription-based pricing, with value calculators suggesting per-study economics.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise/SaaS subscription for hospital cardiology departments

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Ligence product offering

Product offering

Core offering

Ligence develops Ligence Heart™, an FDA Cleared and CE-Marked web-based software that uses deep learning neural networks to automatically analyze 2D transthoracic echocardiography (2D TTE) images. The product classifies cardiac views, detects heart cycle phases, performs automated measurements (e.g., ejection fraction, LV dimensions, strain), and generates guideline-based echocardiography reports (EACVI, BSE, ASE) for hospital cardiology departments and PACS vendors.

Product overview

Ligence offers a unified cardiac diagnostics platform centered on Ligence Heart™, an FDA Cleared and CE-Marked echocardiography analysis software. The core product automates cardiac ultrasound analysis using deep learning for view classification, image segmentation, and automated measurements. An add-on module, Ligence Heart for PACS, extends these capabilities to external PACS systems through DICOM integration. The platform generates structured diagnostic reports following clinical guidelines (EACVI, BSE, ASE) and targets cardiologists and sonographers to reduce echocardiography reporting time and improve diagnostic accuracy.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ligence Heart™ FDA Cleared and CE-Marked web-based echocardiography analysis and reporting software that automates cardiac ultrasound image analysis using deep learning. It classifies heart views (PLAX, A2CH, A3CH, A4CH), detects systolic and diastolic phases, performs automated measurements (EF, LV dimensions, transmitral E/A velocities, tissue Doppler, strain), and generates structured reports following EACVI, BSE, or ASE guidelines for cardiologists and sonographers.
  • Ligence Heart for PACS Integration module for PACS vendors and radiology networks that embeds Ligence's automated echocardiography measurements and analysis into PACS platforms via DICOM SR/GSPS formats, including an HTML5 DICOM viewer. Designed for PACS companies seeking to add AI-powered echocardiography capability without in-house R&D investment.

Quantifiable outcome

  • 15 minutes saved per patient in echocardiography reporting
  • +2 more outcomes

Companies that use Ligence

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Ligence technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature7 records

Ligence partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered partner.

  • ClariuspartnerTechnology or IntegrationClarius is listed as a partner on Ligence's website. Clarius produces handheld ultrasound scanners, and the partnership likely involves integration of Ligence's AI-powered echocardiography analysis with Clarius ultrasound devices.
  • CARPLpartnerTechnology or IntegrationCARPL is listed as a partner on Ligence's website. CARPL is a radiology AI platform that enables integration of multiple AI models; the partnership likely involves CARPL hosting or distributing Ligence's cardiac AI within its platform ecosystem.
  • DeepCpartnerTechnology or IntegrationDeepC is listed as a partner on Ligence's website. DeepC provides a deep learning infrastructure platform, and the partnership may relate to AI model deployment, training infrastructure, or joint go-to-market in the radiology AI space.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Ligence competitors and assessment

Company assessment

Direct peers

  • Caption Health: AI-powered echocardiography guidance and analysis software, acquired by GE HealthCare in 2024. Direct competitor in automated cardiac ultrasound measurement and reporting for cardiology workflows.
  • Ultromics: UK-based AI echocardiography company offering EchoWeave and EchoGo for automated cardiac analysis including strain and HFpEF detection. Directly competes with Ligence Heart in automated echo measurement and reporting for hospital cardiology departments.
  • Us2.ai: Singapore-based AI echocardiography platform automating cardiac measurements and reporting for clinical and clinical trial use. Competes head-to-head with Ligence Heart in automated echo analysis.
  • TOMTEC Imaging Systems: Echocardiography analysis software (now part of Philips) automating 2D/3D cardiac measurements including strain and 3D volumes. Long-standing specialist peer in clinical echo analysis and reporting that Ligence competes with directly.

Broad incumbents

  • Philips (HeartModel / EPIQ CVx AI): Global ultrasound OEM integrating AI-based cardiac quantification (e.g., HeartModel) into its EPIQ/Affiniti platforms. A broad incumbent that bundles AI echo features natively into PACS-connected systems, putting competitive pressure on standalone AI vendors like Ligence.
  • GE HealthCare: Global imaging OEM and ultrasound vendor that acquired Caption Health. Competes with Ligence by bundling AI-driven echo automation into its Vscan Air and premium ultrasound consoles plus Centricity PACS.
  • Siemens Healthineers (AI-Rad Companion / eSie Measure): Cardiac imaging AI features integrated into Siemens ACUSON ultrasound and syngo.via platforms, providing automated echo measurements and broader radiology AI that overlaps with Ligence's analysis-and-reporting value proposition.

Emerging players

  • Circle Cardiovascular Imaging: AI-driven cardiac MR and CT analysis platform. Overlaps with Ligence's automated measurement approach and represents a cross-modality competitor that could expand into echo.
  • HeartVista: AI-driven cardiac MRI acquisition and analysis platform. Comparable in clinical AI positioning and FDA-clearance trajectory, with potential future overlap in multi-modality cardiac diagnostics.

Regional players

  • EchoNous: AI-enabled handheld/portable ultrasound with embedded cardiac measurement automation. Comparable in combining AI with echo to automate cardiac workflows, but sold more as a device-plus-AI bundle rather than pure software like Ligence Heart.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Ligence social profiles

Digital presence

Ligence compliance and trust

Trust signal

Compliance4 records

Ligence financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ligence leadership team

Management profile

Number of profiles

Profiles5 records

Ligence funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ligence M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ligence

What does Ligence do?

Ligence develops Ligence Heart™, an FDA Cleared and CE-Marked web-based software that uses deep learning neural networks to automatically analyze 2D transthoracic echocardiography (2D TTE) images. The product classifies cardiac views, detects heart cycle phases, performs automated measurements (e.g., ejection fraction, LV dimensions, strain), and generates guideline-based echocardiography reports (EACVI, BSE, ASE) for hospital cardiology departments and PACS vendors.

Is Ligence a public or private company?

Ligence is a private company. It is classified as venture growth investor backed and is currently operating.

When was Ligence founded?

Ligence was founded in 2020. It employs 11 to 50 people.

Where is Ligence based?

Ligence is headquartered in Vilnius, Lithuania, in the Europe region.

How does Ligence make money?

One revenue line is on record: ligence Heart SaaS Subscription.

Who are Ligence's main competitors?

Direct peers on record are Caption Health, Ultromics, Us2.ai and TOMTEC Imaging Systems. Broad incumbents are Philips (HeartModel / EPIQ CVx AI), GE HealthCare and Siemens Healthineers (AI-Rad Companion / eSie Measure). Emerging players are Circle Cardiovascular Imaging and HeartVista. EchoNous is listed as a regional player.

Does Ligence have an API?

No public API is recorded for Ligence.

What industry is Ligence in?

Ligence's product category is Cardiac Ultrasound AI Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5132.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioProcess InternationalSmart algorithms, smarter manufacturingThis feature article examines how pharmaceutical and biotech companies are adopting artificial intelligence across drug discovery, biomanufacturing, and medical diagnostics, featuring Lithuanian biotech Biomatter using AI to design enzymes, Insilico Medicine discovering a drug candidate via generative AI, and biotech firm Ligence developing AI for echocardiogram interpretation. While highlighting benefits such as accelerated R&D timelines and improved production efficiency, the article also raises concerns about AI hallucinations, biased training data, intellectual property issues, and significant environmental impacts from data centers. Industry experts suggest that as legislation catches up with AI innovation, companies will need to ensure ethically sourced data with proper safeguards for successful implementation.ArcticstartupLithuanian startup gains €3M to expand AI-driven echocardiography solution across global marketsLithuanian startup Ligence has secured €3 million in seed funding led by Simpact Ventures to expand its AI-driven echocardiography solution globally. The capital will support the company's expansion into new markets and ongoing clinical trials, including those in the United States. This investment underscores investor confidence in Ligence's ability to improve cardiac diagnostics and reduce clinical workloads.CoinvestLigence successfully attracts €3 million investment for cardiac echo softwareLigence, a MedTech startup specializing in AI-driven cardiac echo software, successfully closed an early-stage seed investment round totaling €3 million. The funding was led by Polish VC Simpact Ventures, with significant contributions from Coinvest Capital and other partners including the EIC Fund and 9NGLS. This capital injection supports the company's ongoing clinical trials and expansion of its diagnostic solutions across European and international markets.VestbeeLithuanian startup Ligence secures €3M for its cardiac echo softwareLithuanian startup Ligence has secured €3 million in early-stage seed funding led by Simpact Ventures, with participation from Coinvest Capital and the European Innovation Council. The company develops AI-powered software for cardiac echocardiography that automates image analysis to assist cardiologists. This capital will be used to enhance its software and expand clinical trials currently underway in several countries including the US, Germany, and Poland.Startup LithuaniaAt the Lithuanian-American Innovation Awards, the first place goes for the innovative solution for remote operationsThe Lithuanian-American Innovation Awards ceremony honored three companies for their biotechnology and medical innovations developed in cooperation with US partners. Inovatyvi medicina won first place for its Sentante robotic surgery system, while Ligence received second place for an AI-based cardiac analysis tool, and Vugene was awarded a special social impact prize for epigenetics research. The event highlighted the growing collaboration between Lithuanian and American entities in high-tech sectors such as medicine and defense.EhrconceptsHealth IT Startups Shaking Up the Industry in 2023A two-part report on healthcare IT trends profiles startups across AI, IoMT, telemedicine, big data, 3D printing, blockchain, cloud and genomics. Examples include Care AI's autonomous patient monitoring, Ligence's CardioEchoAI ultrasound tool, Uventions' UV-C disinfection, and Allelica's polygenic risk prediction. The article notes the listed companies only cover part of the research findings.